TZAP Mutation Leads to Poor Prognosis of Patients with Breast Cancer .

Medicina (Kaunas)

Department of Anatomy, School of Medicine, Keimyung University, Daegu 42601, Korea.

Published: November 2019

ZBTB48 is a telomere-associated factor that has been renamed as telomeric zinc finger-associated protein (TZAP). It binds preferentially to long telomeres, competing with telomeric repeat factors 1 and 2. We analyzed the TZAP mutation in 128 breast carcinomas (BCs). In addition, its association with telomere length was investigated. The TZAP mutation (c.1272 G > A, L424L) was found in 7.8% (10/128) of the BCs and was associated with the N0 stage. BCs with the TZAP mutation had longer telomeres than those without this mutation. Survival analysis showed that the TZAP mutation resulted in poorer overall survival. : These results suggest that the TZAP mutation is a possible prognostic marker in BC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915578PMC
http://dx.doi.org/10.3390/medicina55110748DOI Listing

Publication Analysis

Top Keywords

tzap mutation
24
tzap
7
mutation
6
mutation leads
4
leads poor
4
poor prognosis
4
prognosis patients
4
patients breast
4
breast cancer
4
cancer zbtb48
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!